Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | DUT | P33316 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8030008 | 0.93 | ALDH1A1 (0.44) | ALDH1A1TP53DUTTSHR | |
| SCHEMBL10702400 | 0.88 | TSHR (0.36) | ALDH1A1TP53DUTTSHR | |
| SCHEMBL4590603 | 0.82 | ALDH1A1 (0.41) | ALDH1A1DUTTSHR | |
| SCHEMBL875754 | 0.82 | DUT (0.39) | ALDH1A1DUT | |
| SCHEMBL28516260 | 0.82 | DUT (0.39) | TP53DUT | |
| SCHEMBL7484513 | 0.81 | DUT (0.38) | DUT | |
| SCHEMBL28915925 | 0.79 | ALDH1A1 (0.46) | ALDH1A1TP53TSHR | |
| Lithium Ion SCHEMBL15778648 | 0.79 | CA1 (0.38) | DUT | |
| SCHEMBL19543597 | 0.79 | DUT (0.37) | DUT | |
| SCHEMBL11635954 | 0.79 | TSHR (0.50) | ALDH1A1DUTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115353475-B | Preparation method of levetiracetam | 浙江京新药业股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-115353475-A | Preparation method of levetiracetam | 浙江京新药业股份有限公司 | 2022-11-18 | — | — | CN | disclosed |
| US-20070276142-A1 | Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds | CHEMINOVA A/S (DK) | 2007-11-29 | — | — | US | disclosed |
| EP-1716088-A1 | CATALYTIC ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE ALPHA-HALO-CAR BONYL COMPOUNDS | Cheminova A/S (DK) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005080298-A1 | CATALYTIC ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE α-HALO-CARBONYL COMPOUNDS | CHEMINOVA A/S (DK) | 2005-09-01 | — | — | WO | disclosed |
| US-5248830-A | Enantioselective preparation of acetylenic or olefinic substituted cycloalkenyl dihydroxybutyrates and 4-hydroxy-tetrahydro-pyran-2-ones | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1993-09-28 | — | — | US | disclosed |
| WO-1992014692-A1 | ENANTIOSELECTIVE PREPARATION OF ACETYLENIC OR OLEFINIC SUBSTITUTED CYCLOALKENYL DIHYDROXYBUTYRATES AND 4-HYDROXY-TETRAHYDROPYRAN-2-ONES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276142-A1 | Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds | CBR1, CBR3, HAO1 | ALDH1A1 762/4885TP53 3461/4885DUT 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.